Status:
COMPLETED
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..
Lead Sponsor:
AstraZeneca
Conditions:
Nerve Pain
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgia.
Eligibility Criteria
Inclusion
- Provision of signed informed consent form
- Males and female patients aged 18 to 80 years
- Patients with neuropathic pain due to peripheral nerve injury caused by trauma or surgery
Exclusion
- Other paint that may confound assessment of neuropathic pain
- History of treatment failure with more than three adequate trials of treatment for neuropathic pain
- Central neuropathic pain conditions (caused by Central Nervous System injury/disease, eg. Stroke)
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT01200524
Start Date
October 1 2010
End Date
April 1 2012
Last Update
April 25 2014
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Pleven, Bulgaria
2
Research Site
Sofia, Bulgaria
3
Research Site
Aalborg, Denmark
4
Research Site
Odense, Denmark